Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in Chinese hemodialysis patients with secondary hyperparathyroidism
ChiCTR-OIC-17011089Phase 4Recruiting
- Sponsor
- Jinling Hospital
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cinacalcet in secondary hyperparathyroidism (SHPT) (3 arms), sponsored by Jinling Hospital. Primary endpoint: Proportion of patients reaching iPTH target at week 20 and week 32. Started Apr 2017; status: recruiting.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on ChiCTR-OIC-17011089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-17011089.